Abstract
Cancer patients often develop mental conditions, including anxiety and depressive disorder. And, patients with chemotherapy often exhibit mental changes including anxiety and depressive disorder. Furthermore, it is well known that the frequency of delirium is increased in cancer patients receiving terminal care. Thus, the psychiatric and cognitive functions of cancer survivors are significantly influenced by their quality of life. In this study, we performed a retrospective analysis to identify the risk factors for psychiatric disorders in lung cancer survivors. Most lung cancer survivors that were diagnosed with psychiatric disorders had stage 4 disease. In addition, it was found that an increase in disease stage and high doses of opioids are associated with an increased risk of psychiatric disorders in lung cancer survivors. These findings suggest that it is necessary to consider the mental changes experienced by lung cancer patients during disease progression.
| Original language | English |
|---|---|
| Pages (from-to) | 241-246 |
| Number of pages | 6 |
| Journal | Yakugaku Zasshi |
| Volume | 137 |
| Issue number | 2 |
| DOIs |
|
| Publication status | Published - 2017 |
Fingerprint
Keywords
- Delirium
- Lung cancer
- Psychiatric disorder
- Retrospective study
ASJC Scopus subject areas
- Pharmacology
- Pharmaceutical Science
Cite this
Investigation of mental disorders in lung cancer outpatients : A retrospective analysis. / Nakamura, Yuka; Kanemoto, Erika; Kajizono, Makoto; Kitamura, Yoshihisa; Sendo, Toshiaki.
In: Yakugaku Zasshi, Vol. 137, No. 2, 2017, p. 241-246.Research output: Contribution to journal › Comment/debate
}
TY - JOUR
T1 - Investigation of mental disorders in lung cancer outpatients
T2 - A retrospective analysis
AU - Nakamura, Yuka
AU - Kanemoto, Erika
AU - Kajizono, Makoto
AU - Kitamura, Yoshihisa
AU - Sendo, Toshiaki
PY - 2017
Y1 - 2017
N2 - Cancer patients often develop mental conditions, including anxiety and depressive disorder. And, patients with chemotherapy often exhibit mental changes including anxiety and depressive disorder. Furthermore, it is well known that the frequency of delirium is increased in cancer patients receiving terminal care. Thus, the psychiatric and cognitive functions of cancer survivors are significantly influenced by their quality of life. In this study, we performed a retrospective analysis to identify the risk factors for psychiatric disorders in lung cancer survivors. Most lung cancer survivors that were diagnosed with psychiatric disorders had stage 4 disease. In addition, it was found that an increase in disease stage and high doses of opioids are associated with an increased risk of psychiatric disorders in lung cancer survivors. These findings suggest that it is necessary to consider the mental changes experienced by lung cancer patients during disease progression.
AB - Cancer patients often develop mental conditions, including anxiety and depressive disorder. And, patients with chemotherapy often exhibit mental changes including anxiety and depressive disorder. Furthermore, it is well known that the frequency of delirium is increased in cancer patients receiving terminal care. Thus, the psychiatric and cognitive functions of cancer survivors are significantly influenced by their quality of life. In this study, we performed a retrospective analysis to identify the risk factors for psychiatric disorders in lung cancer survivors. Most lung cancer survivors that were diagnosed with psychiatric disorders had stage 4 disease. In addition, it was found that an increase in disease stage and high doses of opioids are associated with an increased risk of psychiatric disorders in lung cancer survivors. These findings suggest that it is necessary to consider the mental changes experienced by lung cancer patients during disease progression.
KW - Delirium
KW - Lung cancer
KW - Psychiatric disorder
KW - Retrospective study
UR - http://www.scopus.com/inward/record.url?scp=85011382341&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85011382341&partnerID=8YFLogxK
U2 - 10.1248/yakushi.16-00226
DO - 10.1248/yakushi.16-00226
M3 - Comment/debate
C2 - 28154337
AN - SCOPUS:85011382341
VL - 137
SP - 241
EP - 246
JO - Yakugaku Zasshi
JF - Yakugaku Zasshi
SN - 0031-6903
IS - 2
ER -